va semaglutide North Texas Health Care System is recruiting veterans for a GLP-1 trial Why Isn't Semaglutide Working? -

Formulations such as Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide) are approved for adults with a BMI of 30 or higher, or 27 and above if accompanied by conditions like high blood pressure or cholesterol

Non-surgical treatments accumulate when repeated

The evidence suggests that tirzepatides dual-receptor mechanism offers enhanced weight loss and metabolic benefits for many patients

Long-term data on sustained weight loss maintenance with continued GLP-1 receptor agonist therapy in post-bariatric populations remains limited, highlighting the need for ongoing research and extended follow-up studies

doi: 10.1016/j.physbeh.2015.06.013 189 SteinbergE